Oncology (all articles)
Review: Current treatment and future directions in the management of anal cancer.
1 Dec, 2021 | 08:38h | UTC
M-A (mostly observational studies): Comparison of gastrojejunostomy to endoscopic stenting for gastric outlet obstruction.
30 Nov, 2021 | 10:08h | UTC
Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice.
30 Nov, 2021 | 09:55h | UTC
Commentary on Twitter
Advances in #BreastCancer radiotherapy allow shorter regimens and reduced toxicities. This #JCOOP Clinical review summarizes the latest evidence in #radonc for #bcsm @CshahMD ➡️ https://t.co/JxvU5FSQlv pic.twitter.com/GOcwAFJzRm
— Journal of Clinical Oncology (@JCO_ASCO) October 31, 2021
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
28 Nov, 2021 | 21:22h | UTCExecutive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report
Full Guideline: Screening for Lung Cancer: CHEST Guideline and Expert Panel Report
News Release: CHEST releases expert guidelines for lung cancer screening – Elsevier
Related:
Commentary on Twitter
CHEST Guidelines and Expert Panel Report contains 16 evidence-based recommendations for the benefits, harms, and implementation of low-dose chest computed tomography (CT) screening. https://t.co/4mvjEOftQl #CHESTOnc #CHESTGuidelines #LungCancerAwarenessMonth pic.twitter.com/uyh9Pf0s5s
— CHEST® Journal (@journal_CHEST) November 23, 2021
Guideline on Cutaneous Angiosarcomas – Update 2021.
26 Nov, 2021 | 10:00h | UTCS1-Guideline Cutaneous Angiosarcomas – Update 2021 – Journal of the German Society of Dermatology
M-A: Treatment for gastrointestinal and pancreatic neuroendocrine tumors.
26 Nov, 2021 | 09:53h | UTCSummary: Treatment options for neuroendocrine tumours – Cochrane Library
Closure of Temporary Ileostomy 2 Versus 12 Weeks After Rectal Resection for Cancer: A Word of Caution from a Prospective, Randomized Controlled Multicenter Trial.
26 Nov, 2021 | 09:42h | UTC
Clinical practice guideline for the treatment of malignant ascites.
25 Nov, 2021 | 10:28h | UTC
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
25 Nov, 2021 | 10:23h | UTCCommentaries:
Related: WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists.
M-A: Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy.
23 Nov, 2021 | 08:21h | UTC
Consensus Statement: U.S. Multi-Society Task Force on Colorectal Cancer now suggests average-risk CRC screening begins at age 45.
21 Nov, 2021 | 23:01h | UTCRelated:
State of the Art Review: Screening and prevention of colorectal cancer.
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
ACG Clinical Guidelines: Start colorectal cancer screening at 45
Recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic.
19 Nov, 2021 | 10:33h | UTC
Long-term results of RCT: Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer.
19 Nov, 2021 | 10:15h | UTCChemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Author Interview: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer – JAMA Oncology
Commentary on Twitter
Secondary analysis of 311 pts on ARO-12 trial of variant approaches to total neoadjuvant therapy (TNT) w/combo of chemo & concurrent chemoradiation (CRT) for rectal cancer shows best results w/up-front CRT then chemo & resection led to best results https://t.co/7cpv5cb1Fr #CRCSM pic.twitter.com/bxfz9Fi5OB
— JAMA Oncology (@JAMAOnc) November 18, 2021
Review: Treatment selection in first-line metastatic renal cell carcinoma—the contemporary treatment paradigm in the age of combination therapy.
19 Nov, 2021 | 10:14h | UTCTreatment Selection in First-line Metastatic Renal Cell Carcinoma—The Contemporary Treatment Paradigm in the Age of Combination Therapy: A Review – JAMA Oncology (free for a limited period)
RCT: An exercise program reduced upper limb disability one year after non-reconstructive breast cancer surgery.
18 Nov, 2021 | 08:39h | UTCCommentaries:
Exercise reduces upper limb disability after breast cancer surgery – BMJ / News Medical
Exercise Helps Ease Arm, Shoulder Pain After Breast Cancer Surgery- HealthDay
Structured Exercise Improves Upper Limb Function After Breast Ca Surgery – Physician’s Weekly
Commentary on Twitter
Women who exercise shortly after having non-reconstructive breast cancer surgery appear to regain better shoulder and arm mobility and experience less pain than those who receive standard care, finds this study @jxbruce https://t.co/BhIKb8RRjV
— The BMJ (@bmj_latest) November 11, 2021
Nursing care for oncologic patients undergoing surgery using an enhanced recovery approach.
17 Nov, 2021 | 08:22h | UTCOncologic Surgical Care Using an Enhanced Recovery Approach – AACN Advanced Critical Care
News release: Enhanced Recovery Approach Changes Care for Surgical Oncology Patients – American Association of Critical-Care Nurses
Related: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Review: Treatment landscape of triple-negative breast cancer — expanded options, evolving needs.
16 Nov, 2021 | 08:23h | UTCTreatment landscape of triple-negative breast cancer — expanded options, evolving needs – Nature Reviews Clinical Oncology (free for a limited period)
Commentary on Twitter
A Review in @NatRevClinOncol describes the current and upcoming therapeutic landscape of triple-negative breast cancer. https://t.co/bcFTef01t1 pic.twitter.com/zFPyeeCnD5
— Nature Portfolio (@NaturePortfolio) November 15, 2021
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab.
16 Nov, 2021 | 08:14h | UTCLong-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study – The Lancet Oncology (link to abstract – $ for full-text)
Original Study: Study: Combination Immunotherapy for Melanoma Brain Metastases
SARS-CoV-2 vaccines are safe and immunogenic in most people with cancer, according to study.
14 Nov, 2021 | 20:05h | UTCNews Release: SARS-CoV-2 vaccines are safe and immunogenic in most people with cancer, according to study – Harvard Medical School
Original study: Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – Journal of Clinical Oncology
Commentary from the author on Twitter (thread – click for more)
The CANVAX study is out in @JCO_ASCO! https://t.co/WKrU6dQIEB
Grateful to >1000 CANVAX participants, study leads ( @JustinGainor, @MGHPathology, @BalazsLab) and so many co-authors incl. @arthur_kim_ID, @KimberlyBlumen1, @joanhowMD, @dradityabardia
Much more to come!— Vivek Naranbhai, MD, PhD, DPhil (@vivek_naranbhai) November 10, 2021
Among patients with cancer who received decompressive G-tubes for nutrition or malignant bowel obstruction, nearly half presented with stage IV disease and died within one month of placement.
12 Nov, 2021 | 09:55h | UTCCommentary: Risks and Benefits Associated With Gastrostomy Tubes for Patients With Cancer – The ASCO Post
Some immune checkpoint inhibitors can cause serious arrhythmias and myocarditis.
12 Nov, 2021 | 09:57h | UTCOriginal study: Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis – Circulation (link to abstract – $ for full-text)
Related:
Clinical Review on the Management of Hormone Receptor–Positive Metastatic Breast Cancer.
11 Nov, 2021 | 08:32h | UTC
RCT: One-time flexible sigmoidoscopy screening is associated with long-term reduction in colorectal cancer incidence and mortality.
10 Nov, 2021 | 07:04h | UTCCommentaries:
Large observational study suggests prolactin-increasing antipsychotics are associated with increased risk of breast cancer (OR=1.56 for over 5 years of exposure); prolactin-sparing antipsychotics (including clozapine, quetiapine, or aripiprazole), on the other hand, were not associated with increased risk.
10 Nov, 2021 | 06:57h | UTCAntipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
Nested case-control study: ≥5 years exposure to prolactin-sparing APDs was not associated with an increased risk of breast cancer vs.<1 year exposure (aOR=1.19; 0.90–1.58). The opposite was observed with APDs that increase prolactin (aOR=1.56; 1.27–1.92) https://t.co/LwCVyTH051
— P𝘧OL (@psychopharmacol) September 12, 2021
Cohort study: In utero exposure to 17α-hydroxyprogesterone caproate linked to increased risk of cancer in offspring.
10 Nov, 2021 | 06:59h | UTCIn utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring – American Journal of Obstetrics and Gynecology (link to abstract – $ for full-text)